CIK 0001818794
- Large accelerated filer
Dyne Therapeutics, Inc.
Sign in to watch- Ticker
- DYN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364883909
- Phone
- +1 781-786-8230
- Business address
- 1560 TRAPELO ROAD, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $40,000
- in 1 filing
- Open-market sales, last 90 days
- $247,777
- in 3 filings, $248K under 10b5-1 plans
Net −$207,777. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-08 | Cox John CEO & President | Sale 10b5-1 | −5,658 | $18.88 | $107K | 357,507 |
| 2026-08-13 | Cox John CEO & President | Sale 10b5-1 | −4,986 | $26.28 | $131K | 363,165 |
| 2026-06-16 | Cox John CEO & President | Sale 10b5-1 | −2,683 | $18.33 | $49K | 368,151 |
| 2026-05-13 | Cox John CEO & President | Sale 10b5-1 | −3,311 | $18.36 | $61K | 370,834 |
| 2026-03-05 | Cox John CEO & President | Sale 10b5-1 | −2,732 | $14.90 | $41K | 374,145 |
| 2026-02-12 | Cox John CEO & President | Grant or award | +180,000 | 376,877 | ||
| 2026-02-12 | Cox John CEO & President | Grant or award · Stock option (right to buy) | +285,000 | 285,000 | ||
| 2025-12-05 | Cox John CEO & President | Sale 10b5-1 | −2,662 | $20.72 | $55K | 196,877 |
| 2025-09-05 | Cox John CEO & President | Sale 10b5-1 | −2,640 | $13.41 | $35K | 199,539 |
| 2025-07-16 | Cox John CEO & President | Grant or award · Stock option (right to buy) | +197,285 | 197,285 | ||
| 2025-07-15 | Cox John CEO & President | Gift | −10,000 | 232,179 | ||
| 2025-07-15 | Cox John CEO & President | Gift | −10,000 | 222,179 | ||
| 2025-07-15 | Cox John CEO & President | Gift | −10,000 | 212,179 | ||
| 2025-07-15 | Cox John CEO & President | Gift | −10,000 | 202,179 | ||
| 2025-07-14 | Cox John CEO & President | Purchase | +100,000 | $9.11 | $911K | 242,179 |
| 2025-06-05 | Cox John CEO & President | Sale 10b5-1 | −4,060 | $13.35 | $54K | 142,179 |
| 2025-03-05 | Cox John CEO & President | Sale 10b5-1 | −4,061 | $11.83 | $48K | 146,239 |
| 2024-12-04 | Cox John CEO & President | Grant or award | +145,300 | 150,300 | ||
| 2024-12-04 | Cox John CEO & President | Grant or award · Stock option (right to buy) | +232,100 | 232,100 | ||
| 2024-09-04 | Cox John CEO & President | Purchase | +800 | $32.57 | $26K | 800 |
Page 1 of 2 · 28 trades